Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-10 00:16 | 2022-08-05 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $24.74 | 2,500 | $61,858 | 651,871 | -0.4% |
| 2022-08-09 23:34 | 2022-08-05 | ARQT | Arcutis Biotherapeutics Inc. | Frazier Life Sciences VIII, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $20.00 | 250,000 | $5,000,000 | 8,684,232 | +3.0% |
| 2022-07-19 01:53 | 2022-07-18 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $24.40 | 6,000 | $146,374 | 180,208 | -3.2% |
| 2022-07-13 02:30 | 2022-07-08 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $25.37 | 13,500 | $342,473 | 651,871 | -2.0% |
| 2022-07-13 02:30 | 2022-07-08 | ARQT | Arcutis Biotherapeutics Inc. | OSBORNE DAVID W | Officer; Chief Technical Officer | Pharmaceutical Preparations | SALE | $25.41 | 2,197 | $55,835 | 256,649 | -0.8% |
| 2022-07-07 23:04 | 2022-07-06 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | SALE | $22.07 | 1,000 | $22,070 | 658,284 | -0.2% |
| 2022-06-28 23:29 | 2022-06-24 | ARQT | Arcutis Biotherapeutics Inc. | ORBIMED ADVISORS LLC | 10% owner | Pharmaceutical Preparations | SALE | $21.31 | 341,971 | $7,287,402 | 415,142 | -45.2% |
| 2022-06-06 23:06 | 2022-06-06 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | SALE | $21.06 | 1,000 | $21,064 | 659,284 | -0.2% |
| 2022-06-02 23:48 | 2022-06-02 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; SVP and General Counsel | Pharmaceutical Preparations | SALE | $19.73 | 1,795 | $35,419 | 16,380 | -9.9% |
| 2022-06-02 23:48 | 2022-06-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $20.62 | 2,500 | $51,539 | 181,896 | -1.4% |
| 2022-05-06 00:31 | 2022-05-05 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | SALE | $21.76 | 1,000 | $21,760 | 658,667 | -0.2% |
| 2022-05-04 00:14 | 2022-05-02 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $20.44 | 2,500 | $51,112 | 181,896 | -1.4% |
| 2022-04-22 01:32 | 2022-04-21 | ARQT | Arcutis Biotherapeutics Inc. | OSBORNE DAVID W | Officer; Chief Technical Officer | Pharmaceutical Preparations | SALE | $20.42 | 2,197 | $44,872 | 257,229 | -0.8% |
| 2022-04-09 01:06 | 2022-04-06 | ARQT | Arcutis Biotherapeutics Inc. | ORBIMED ADVISORS LLC | 10% owner | Pharmaceutical Preparations | SALE | $20.68 | 878,200 | $18,163,635 | 451,086 | -66.1% |
| 2022-04-06 01:45 | 2022-04-05 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | SALE | $21.43 | 1,000 | $21,430 | 659,667 | -0.2% |
| 2022-04-01 23:55 | 2022-04-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $20.02 | 7,500 | $150,184 | 181,896 | -4.0% |
| 2022-03-12 05:42 | 2022-03-09 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | SALE | $17.00 | 300 | $5,100 | 660,667 | 0.0% |
| 2022-03-08 04:59 | 2022-03-04 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $16.90 | 3,259 | $55,088 | 660,967 | -0.5% |
| 2022-03-08 04:49 | 2022-03-04 | ARQT | Arcutis Biotherapeutics Inc. | Lock Kenneth A. | Officer; Chief Commercial Officer | Pharmaceutical Preparations | SALE | $16.85 | 1,023 | $17,234 | 44,011 | -2.3% |
| 2022-03-08 04:49 | 2022-03-04 | ARQT | Arcutis Biotherapeutics Inc. | Burrows Scott L | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $16.85 | 303 | $5,104 | 35,256 | -0.9% |
| 2022-03-08 04:48 | 2022-03-04 | ARQT | Arcutis Biotherapeutics Inc. | Turney Patricia A. | Officer; SVP, Operations | Pharmaceutical Preparations | SALE | $16.85 | 1,023 | $17,234 | 31,113 | -3.2% |
| 2022-03-08 04:53 | 2022-03-04 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $16.85 | 1,011 | $17,032 | 43,039 | -2.3% |
| 2022-03-08 04:47 | 2022-03-04 | ARQT | Arcutis Biotherapeutics Inc. | OSBORNE DAVID W | Officer; Chief Technical Officer | Pharmaceutical Preparations | SALE | $16.85 | 856 | $14,420 | 259,426 | -0.3% |
| 2022-03-04 00:18 | 2022-03-01 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | SALE | $17.75 | 2,153 | $38,222 | 592,626 | -0.4% |
| 2022-03-04 00:17 | 2022-03-01 | ARQT | Arcutis Biotherapeutics Inc. | Burrows Scott L | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $17.75 | 420 | $7,456 | 22,259 | -1.9% |
| 2022-03-04 00:16 | 2022-03-01 | ARQT | Arcutis Biotherapeutics Inc. | Turney Patricia A. | Officer; SVP, Operations | Pharmaceutical Preparations | SALE | $17.75 | 936 | $16,617 | 18,836 | -4.7% |
| 2022-03-04 00:15 | 2022-03-01 | ARQT | Arcutis Biotherapeutics Inc. | Lock Kenneth A. | Officer; Chief Commercial Officer | Pharmaceutical Preparations | SALE | $17.75 | 935 | $16,599 | 31,734 | -2.9% |
| 2022-03-04 00:18 | 2022-03-01 | ARQT | Arcutis Biotherapeutics Inc. | OSBORNE DAVID W | Officer; Chief Technical Officer | Pharmaceutical Preparations | SALE | $17.75 | 775 | $13,758 | 246,982 | -0.3% |
| 2022-02-12 01:55 | 2022-02-09 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $17.00 | 1,000 | $17,000 | 594,779 | -0.2% |
| 2022-01-08 00:17 | 2022-01-05 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $21.59 | 1,000 | $21,592 | 594,779 | -0.2% |
| 2022-01-06 01:19 | 2022-01-03 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $21.21 | 2,500 | $53,030 | 181,896 | -1.4% |
| 2021-12-29 01:00 | 2021-12-27 | ARQT | Arcutis Biotherapeutics Inc. | Burrows Scott L | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $20.07 | 12,560 | $252,139 | 22,679 | -35.6% |
| 2021-12-24 05:46 | 2021-12-23 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $20.16 | 2,500 | $50,396 | 181,896 | -1.4% |
| 2021-12-11 02:41 | 2021-12-08 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $17.00 | 1,000 | $17,000 | 594,779 | -0.2% |
| 2021-11-10 01:19 | 2021-11-05 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $21.50 | 1,000 | $21,502 | 594,779 | -0.2% |
| 2021-11-04 00:16 | 2021-11-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $21.81 | 2,500 | $54,524 | 181,896 | -1.4% |
| 2021-10-07 23:05 | 2021-10-05 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $24.92 | 2,500 | $62,294 | 594,779 | -0.4% |
| 2021-10-05 21:11 | 2021-10-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $23.87 | 2,500 | $59,680 | 181,896 | -1.4% |
| 2021-10-05 21:10 | 2021-10-01 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $25.01 | 1,500 | $37,510 | 594,779 | -0.3% |
| 2021-09-10 00:42 | 2021-09-07 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $21.14 | 1,000 | $21,137 | 594,779 | -0.2% |
| 2021-09-04 00:07 | 2021-09-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $20.80 | 5,000 | $103,987 | 181,896 | -2.7% |
| 2021-08-10 01:51 | 2021-08-05 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $20.81 | 1,000 | $20,810 | 594,779 | -0.2% |
| 2021-07-09 02:40 | 2021-07-06 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $26.58 | 1,750 | $46,515 | 594,779 | -0.3% |
| 2021-07-07 02:14 | 2021-07-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $26.13 | 2,200 | $57,476 | 181,896 | -1.2% |
| 2021-06-28 23:11 | 2021-06-24 | ARQT | Arcutis Biotherapeutics Inc. | CHAUDHURI BHASKAR | Director | Pharmaceutical Preparations | SALE | $27.50 | 7,484 | $205,810 | 841,391 | -0.9% |
| 2021-06-24 00:47 | 2021-06-21 | ARQT | Arcutis Biotherapeutics Inc. | CHAUDHURI BHASKAR | Director | Pharmaceutical Preparations | SALE | $27.50 | 2,516 | $69,190 | 848,875 | -0.3% |
| 2021-06-09 23:35 | 2021-06-07 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $26.35 | 1,750 | $46,113 | 594,779 | -0.3% |
| 2021-06-03 23:37 | 2021-06-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $27.09 | 2,200 | $59,603 | 212,553 | -1.0% |
| 2021-06-03 23:39 | 2021-06-01 | ARQT | Arcutis Biotherapeutics Inc. | CHAUDHURI BHASKAR | Director | Pharmaceutical Preparations | SALE | $27.50 | 10,000 | $275,000 | 851,391 | -1.2% |
| 2021-05-11 18:47 | 2021-05-07 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $35.00 | 750 | $26,250 | 593,773 | -0.1% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.